- Home
- DUOT vs OTLK Comparison
DUOT vs OTLK Comparison
Compare DUOT & OTLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DUOT
- OTLK
- Stock Information
- Founded
- DUOT 1990
- OTLK 2010
- Country
- DUOT United States
- OTLK United States
- Employees
- DUOT N/A
- OTLK N/A
- Industry
- DUOT Computer Software: Prepackaged Software
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DUOT Technology
- OTLK Health Care
- Exchange
- DUOT Nasdaq
- OTLK Nasdaq
- Market Cap
- DUOT 34.8M
- OTLK 35.0M
- IPO Year
- DUOT N/A
- OTLK 2016
- Fundamental
- Price
- DUOT $4.76
- OTLK $1.50
- Analyst Decision
- DUOT Strong Buy
- OTLK Strong Buy
- Analyst Count
- DUOT 2
- OTLK 7
- Target Price
- DUOT $8.00
- OTLK $40.57
- AVG Volume (30 Days)
- DUOT 133.7K
- OTLK 4.6M
- Earning Date
- DUOT 11-19-2024
- OTLK 02-12-2025
- Dividend Yield
- DUOT N/A
- OTLK N/A
- EPS Growth
- DUOT N/A
- OTLK N/A
- EPS
- DUOT N/A
- OTLK N/A
- Revenue
- DUOT $7,346,014.00
- OTLK N/A
- Revenue This Year
- DUOT $33.94
- OTLK N/A
- Revenue Next Year
- DUOT $147.69
- OTLK N/A
- P/E Ratio
- DUOT N/A
- OTLK N/A
- Revenue Growth
- DUOT N/A
- OTLK N/A
- 52 Week Low
- DUOT $1.94
- OTLK $0.87
- 52 Week High
- DUOT $6.44
- OTLK $12.85
- Technical
- Relative Strength Index (RSI)
- DUOT 48.60
- OTLK 21.72
- Support Level
- DUOT $3.96
- OTLK $1.35
- Resistance Level
- DUOT $4.49
- OTLK $1.65
- Average True Range (ATR)
- DUOT 0.53
- OTLK 0.22
- MACD
- DUOT -0.11
- OTLK 0.03
- Stochastic Oscillator
- DUOT 27.27
- OTLK 14.03
About DUOT Duos Technologies Group Inc.
Duos Technologies Group Inc operating under its brand name duostech, designs, develops, deploys and operates intelligent technology solutions supporting rail, logistics and intermodal businesses that streamline operations, improve safety and reduce costs. The company's main offering, the Railcar Inspection Portal (RIP), provides both freight and transit railroad customers and select government agencies the ability to conduct fully automated railcar inspections of trains while they are moving at full speed. It has also developed the Automated Logistics Information System (ALIS) which automates gatehouse operations where transport trucks enter and exit large logistics and intermodal facilities. Its segments are Rail, Commercial, Governments, Banking and AI.
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.